发明名称 SPIRO-OXINDOLE COMPOUND AND USE THEREOF AS THERAPEUTIC AGENT
摘要 PROBLEM TO BE SOLVED: To provide a compound useful for treatment and/or prevention of sodium channel mediated diseases or conditions.SOLUTION: The invention relates to a spiro-oxindole compound represented by the formula (I), where k, j, Q, R, R, R, R, R, R, R, R, Rare as defined in the application, or a pharmaceutically acceptable salt, solvate or prodrug as a stereoisomer, an enantiomer, a tautomer of a mixture thereof, and these are useful for treatment and/or prevention of sodium channel mediated diseases or conditions such as pain. There is disclosed a pharmaceutical composition containing the compound, a method for manufacturing the compound and method of using the same.SELECTED DRAWING: None
申请公布号 JP2016056212(A) 申请公布日期 2016.04.21
申请号 JP20160011773 申请日期 2016.01.25
申请人 XENON PHARMACEUTICALS INC 发明人 CHAFEEV MIKHAIL;CHOWDHURY SULTAN;FRASER ROBERT;FU JIANMIN;KAMBOJ RAJENDER;HOU DUANJIE;LIU SHIFENG;BAGHERZADEH MEHRAN SEID;SVIRIDOV SERGUEI;SUN SHAOYI;SUN JIANYU;CHAKKA NAGASREE;HSIEH TOM;RAINA VANDNA
分类号 C07D491/20;A61K31/407;A61K31/4184;A61K31/4192;A61K31/422;A61K31/4245;A61K31/428;A61K31/433;A61K31/4439;A61K31/454;A61K31/4545;A61K31/4709;A61K31/506;A61K31/5377;A61P3/10;A61P5/14;A61P9/06;A61P9/10;A61P19/02;A61P21/00;A61P21/02;A61P21/04;A61P25/00;A61P25/02;A61P25/04;A61P25/08;A61P25/22;A61P25/28;A61P29/00;A61P35/00;A61P43/00;C07D491/107;C07D491/113;C07D513/20 主分类号 C07D491/20
代理机构 代理人
主权项
地址